204 related articles for article (PubMed ID: 32156081)
1. Treatment of Dystrophic
Addinsall AB; Forgan LG; McRae NL; Kelly RW; McDonald PL; McNeill B; McCulloch DR; Stupka N
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32156081
[TBL] [Abstract][Full Text] [Related]
2. Dystrophin-negative slow-twitch soleus muscles are not susceptible to eccentric contraction induced injury over the lifespan of the
Kiriaev L; Kueh S; Morley JW; Houweling PJ; Chan S; North KN; Head SI
Am J Physiol Cell Physiol; 2021 Oct; 321(4):C704-C720. PubMed ID: 34432537
[TBL] [Abstract][Full Text] [Related]
3. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
4. A Reduction in Selenoprotein S Amplifies the Inflammatory Profile of Fast-Twitch Skeletal Muscle in the
Wright CR; Allsopp GL; Addinsall AB; McRae NL; Andrikopoulos S; Stupka N
Mediators Inflamm; 2017; 2017():7043429. PubMed ID: 28592916
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles.
McRae N; Forgan L; McNeill B; Addinsall A; McCulloch D; Van der Poel C; Stupka N
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211034
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
8. Branched fibers from old fast-twitch dystrophic muscles are the sites of terminal damage in muscular dystrophy.
Kiriaev L; Kueh S; Morley JW; North KN; Houweling PJ; Head SI
Am J Physiol Cell Physiol; 2018 Jun; 314(6):C662-C674. PubMed ID: 29412689
[TBL] [Abstract][Full Text] [Related]
9. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
[TBL] [Abstract][Full Text] [Related]
10. Genetic reduction of the extracellular matrix protein versican attenuates inflammatory cell infiltration and improves contractile function in dystrophic mdx diaphragm muscles.
McRae NL; Addinsall AB; Howlett KF; McNeill B; McCulloch DR; Stupka N
Sci Rep; 2020 Jul; 10(1):11080. PubMed ID: 32632164
[TBL] [Abstract][Full Text] [Related]
11. Reduced mitochondrial respiration and increased calcium deposits in the EDL muscle, but not in soleus, from 12-week-old dystrophic mdx mice.
Gaglianone RB; Santos AT; Bloise FF; Ortiga-Carvalho TM; Costa ML; Quirico-Santos T; da Silva WS; Mermelstein C
Sci Rep; 2019 Feb; 9(1):1986. PubMed ID: 30760802
[TBL] [Abstract][Full Text] [Related]
12. An anti-ADAMTS1 treatment relieved muscle dysfunction and fibrosis in dystrophic mice.
Wang Y; Xiao Y; Zheng Y; Yang L; Wang D
Life Sci; 2021 Sep; 281():119756. PubMed ID: 34175316
[TBL] [Abstract][Full Text] [Related]
13. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
[TBL] [Abstract][Full Text] [Related]
14. Hypochlorous acid exposure impairs skeletal muscle function and Ca
Lea TA; Panizza PM; Arthur PG; Bakker AJ; Pinniger GJ
J Physiol; 2023 Dec; 601(23):5257-5275. PubMed ID: 37864413
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice.
Stupka N; Schertzer JD; Bassel-Duby R; Olson EN; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R983-92. PubMed ID: 18199592
[TBL] [Abstract][Full Text] [Related]
16. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
[TBL] [Abstract][Full Text] [Related]
17. Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy.
Carberry S; Brinkmeier H; Zhang Y; Winkler CK; Ohlendieck K
Int J Mol Med; 2013 Sep; 32(3):544-56. PubMed ID: 23828267
[TBL] [Abstract][Full Text] [Related]
18. Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy.
Camerino GM; Cannone M; Giustino A; Massari AM; Capogrosso RF; Cozzoli A; De Luca A
Hum Mol Genet; 2014 Nov; 23(21):5720-32. PubMed ID: 24916377
[TBL] [Abstract][Full Text] [Related]
19. Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds.
Gamberi T; Fiaschi T; Valocchia E; Modesti A; Mantuano P; Rolland JF; Sanarica F; De Luca A; Magherini F
J Proteomics; 2018 Jan; 170():43-58. PubMed ID: 28966053
[TBL] [Abstract][Full Text] [Related]
20. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
